CARL ZEISS MEDITEC AG |
Market Closed -
Other stock markets
|
After market 03:58:00 pm | |||
| 84.85 EUR | +1.01% |
|
85.12 | +0.32% |
| 12:42pm | CARL ZEISS MEDITEC AG : Goldman Sachs reiterates its Sell rating | ZD |
| May. 31 | Carl Zeiss Meditec just above annual low - JPMorgan skeptical | DP |
| Sales 2024 * | 2.23B 2.42B | Sales 2025 * | 2.51B 2.72B | Capitalization | 7.51B 8.16B |
|---|---|---|---|---|---|
| Net income 2024 * | 255M 277M | Net income 2025 * | 312M 339M | EV / Sales 2024 * | 3.55 x |
| Net Debt 2024 * | 396M 430M | Net Debt 2025 * | 345M 375M | EV / Sales 2025 * | 3.13 x |
| P/E ratio 2024 * |
29.5
x | P/E ratio 2025 * |
23.8
x | Employees | 4,950 |
| Yield 2024 * |
1.26% | Yield 2025 * |
1.42% | Free-Float | 40.86% |
More Fundamentals
* Assessed data
More news
Latest transcript on Carl Zeiss Meditec AG
More recommendations
More press releases
More news
| 1 day | +1.10% | ||
| 1 week | -3.08% | ||
| Current month | +0.24% | ||
| 1 month | -15.15% | ||
| 3 months | -28.21% | ||
| 6 months | +4.68% | ||
| Current year | -14.15% |
1 week
82.50
89.75
1 month
82.50101.50
Current year
82.50123.75
1 year
72.60123.75
3 years
72.60202.00
5 years
67.70202.00
10 years
19.83202.00
| Managers | Title | Age | Since |
|---|---|---|---|
Markus Weber
CEO | Chief Executive Officer | 51 | 21-12-30 |
| Director of Finance/CFO | 59 | 18-09-30 | |
Christian Müller
BRD | Director/Board Member | 57 | 09-12-14 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Michael Kaschke
BRD | Director/Board Member | 67 | 01-12-31 |
Karl Lamprecht
CHM | Chairman | 60 | 20-06-24 |
Peter Kameritsch
BRD | Director/Board Member | 55 | 21-05-26 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.71% | 202 M€ | -.--% | ||
| 0.52% | 2 M€ | +13.56% | - | |
| 0.49% | 79 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-05 | 84.85 | +1.01% | 121 759 |
| 24-06-04 | 84 | +0.18% | 188,132 |
| 24-06-03 | 83.85 | -0.95% | 253,919 |
| 24-05-31 | 84.65 | -5.37% | 412,286 |
| 24-05-30 | 89.45 | +2.17% | 116,567 |
Delayed Quote Xetra, June 05, 2024 at 11:35 am EDT
More quotes
Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The Company has various production sites in Europe, the United States and Asia.
Calendar
2024-08-08
- Q3 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
84
EUR
Average target price
103.9
EUR
Spread / Average Target
+23.65%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -14.15% | 8.18B | |
| +8.29% | 217B | |
| +15.70% | 195B | |
| +31.15% | 112B | |
| +3.76% | 65.83B | |
| +13.96% | 52.67B | |
| +4.70% | 49.86B | |
| -3.59% | 38.18B | |
| -0.49% | 35.39B | |
| +23.64% | 31.02B |
- Stock Market
- Equities
- AFX Stock
